SARAH PURLEE: Open Payments
NPI 1174391486 · JEFFERSONVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$859 in 42 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $657 · 2025 $859
Food & beverage: $859
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $227 |
| ABBVIE INC. | 10 | $154 |
| GlaxoSmithKline, LLC. | 5 | $89 |
| Amgen Inc. | 4 | $66 |
| Axsome Therapeutics, Inc. | 3 | $48 |
| Lilly USA, LLC | 2 | $42 |
| Exact Sciences Corporation | 2 | $41 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $40 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $37 |
| Viatris Specialty LLC | 1 | $29 |
Products named: VRAYLAR, FARXIGA, BREZTRI, TRELEGY ELLIPTA, REPATHA, Auvelity, MOUNJARO, Cologuard Collection Kit.
Industry payments across IN — which companies pay providers there.
